Skip to content
Search
Generic filters
API Products
API Sourcing
Strategic Sourcing
505(b)(2) Pathway
Regulatory Support
Logistics
Manufacturer Management Program
CDMO Services
Formulation Development
Solid Dose Delivery Systems
Liquids / Suspensions
Semi-Solids
Suppositories
Commercial Scale-Up Facilities & Equipment
Regulatory Management
Analytical Services
Analytical Testing
Stability Services
Resources
About LGM
Quality Commitment
Leadership
Company History
Clients
News
Events
Careers
Blog
Contact
CONTACT
Listing Page
Tag: COVID-19
The Impact of COVID-19 on Pharma Markets
May 30, 2021
The pandemic has left a substantial impact on our world that will be felt for years to come. It has led...
Read More >
Reshoring Early-Stage Pharma
February 28, 2021
The Emergence of a Post COVID-19 Risk Mitigation Strategy Over the last few decades, pharma companies...
Read More >
Can the U.S. Stop Buying Drugs from China?
October 04, 2020
The SARS-CoV-2 pandemic has drawn significant attention to just how much US pharmaceutical manufacturers...
Read More >
A Look at Reshoring Drug Manufacturing: A Q&A With LGM Pharma’s Hamilton Lenox
June 08, 2020
When SARS-CoV-2 arrived on American shores this Spring, concerns about overextended drug supply chains...
Read More >
Search
Categories
Categories
505b2
Analytical Services
Analytical Testing
API Sourcing
blog
Bulk Active Ingredient
CDMO Services
Compounding API
Dosage Forms
Drug Manufacturing
Drug Research & Development API
Formulation Development
LGM Pharma
Liquids/Suspensions
Logistics
Manufacturer Qualification
Orally disintegrating tablet
Press Release
Quality By Design
Regulatory
Regulatory Management
Regulatory Support
Semi-Solids
SME Article
Solid Dose
Stability Studies
Strategic Sourcing
Supply Chain
Suppository
Vaccine Adjuvants
How can we help?
Contact Us
